Farm Com. 2022 Apr 26;14(2):46-49. doi: 10.33620/FC.2173-9218.(2022/Vol14).002.08

Pharmacotherapeutic follow-up of a diabetic patient during the pandemic in the community pharmacy: clinical case

García Navarro C1, Rodríguez-Arcas MJ2, Sánchez Ortiz JM3
1. Estudiante del Grado de Farmacia, Universidad de Murcia. 2. Farmacéutica comunitaria, Cartagena, Murcia. 3. Profesora titular del Grado en Farmacia, Universidad de Murcia.
García C, Rodríguez-Arcas MJ, Sánchez JM. Seguimiento del paciente crónico durante la pandemia COVID-19 en la farmacia comunitaria: caso clínico. Farm Com. 2022 Apr 26;14(2):46-49. doi: 10.33620/FC.2173-9218.(2022/Vol14).002.08
Abstract : 

The COVID-19 pandemic has been specially damaging for the monitoring of diabetic patients. During the pandemic, pharmacies, which have traditionally been the reference health-care centers for these patients, have been heavily involved in student-training, to respond to the increasingly demand of qualified health-care professionals. During the training period, a 75-aged chronic patient with abdominal symptomatology and abnormally high values of glycosylated haemoglobin and triglycerides (7,7% and 309 mg/dl) was detected.

The possible cause of the abdominal symptomatology was identified as a drug interaction between metformin and OCT1 transporters inhibitors. In addition, an adverse effect of prednisone was detected because of its hyperglycaemic effect, and a potential interaction between repaglinide and clopidogrel through CYP2C8 has been identified as a possible contributor to this condition.

The negative drug results were notified to the physician in a written report. The doctor have accepted the pharmaceutical intervention and the drug treatment was modified. Three months later, the patient’s values of glycosylated haemoglobin and triglycerides dropped to 6,8% and 122mg/dL respectively, both values within the optimum range, and the abdominal symptomatology highly decreased.

To sum up, this case provides a clear example of how medication review with follow-up is an efficient tool to detect efficacy and security problems, and for improving the monitoring of chronic patients in collaboration with their physician.


Article download link: